Reserpine, the major component of alseroxylon
|Chemical and physical data|
|(what is this?)|
Alseroxylon (Rautensin, Rauwiloid) is a norepinephrine reuptake inhibitor that has been investigated in the treatment of hypertension and angina pectoris and as a sedative in psychoses. It was at one time approved for use in the United States, but has since been discontinued.
- Green, R. S.; Davolos, D. (1956). "A long-term study of the effect of crude Rauwolfia serpentina and of its alseroxylon fraction in patients with hypertension". The American Journal of Medicine. 20 (5): 760–773. doi:10.1016/0002-9343(56)90158-9. PMID 13313574.
- DrugBank DB00386
- Approved Drug Products with Therapeutic Equivalence Evaluations. FDA Orange Book (33rd ed.). 2013.